# Contact Wolverine MD: Editorial Inquiries on BPC-157 TB-500

> Contact Wolverine MD for editorial inquiries and corrections about the BPC-157 TB-500 research digest. We do not provide medical advice, dosing, or any product.

For corrections, citation questions, and editorial inquiries about the BPC-157 TB-500 research digest.

## Editorial inquiries

Use the form below for editorial inquiries about the BPC-157 TB-500 research digest — a flagged citation, a study we should add, or a correction to how a finding is summarized. We read every message about the accuracy of the record and prioritize substantive corrections.

What this channel is not: it is not a route to medical advice, dosing guidance, a prescription, or any product. We do not sell, supply, or source the blend or either constituent, and we cannot advise on personal use. Questions of that kind belong with an appropriately licensed prescriber, not with an editorial publisher.

## Send a message

[CONTACT_FORM]

Messages are used only to respond to your inquiry. We do not add you to any list, and we do not share your details. For the regulatory framing that governs what we can and cannot describe, see [Wolverine legal status and 503A compounding access](/legal-status).

---

A two-channel research console: the BPC-157 and TB-500 literature logged to source, with the blend's missing human readouts left blank rather than filled in — not a clinic, not a vendor, not a prescription.